Kenneth Epstein is the co-founder and Chief Commercial Officer of Cannformatics, a biotechnology start-up developing and applying Cannabis-Responsive™ biomarker technology to guide health care providers and patients to evidence-based personalized medical cannabis treatment.
Related Posts
Trump’s Solicitor General Asks Supreme Court For More Time To Weigh Challenge To Gun Ban For Marijuana Consumers
Texas Senate Passes Bill To Ban Cities From Putting Marijuana Decriminalization Initiatives On Local Ballots
